Skip to Content
Merck

Key Documents

View All Documentation

Skip To

T7205

Tegafur

powder

Synonym(s):

5-Fluoro-1-(tetrahydro-2-furyl)uracil, Ftorafur, Tegafur

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice

About This Item

Empirical Formula (Hill Notation):
C8H9FN2O3
CAS Number:
17902-23-7
Molecular Weight:
200.17
NACRES:
NA.77
PubChem Substance ID:
329826861
UNSPSC Code:
12352200
EC Number:
241-846-2
MDL number:
MFCD00012351
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
100
Pricing and availability is not currently available.
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

100

assay

≥98% (HPLC)

form

powder

color

white to off-white

mp

171-173 °C (lit.)

solubility

DMSO: >50 mg/mL

storage temp.

room temp

SMILES string

FC1=CN(C2CCCO2)C(=O)NC1=O

InChI

1S/C8H9FN2O3/c9-5-4-11(6-2-1-3-14-6)8(13)10-7(5)12/h4,6H,1-3H2,(H,10,12,13)

InChI key

WFWLQNSHRPWKFK-UHFFFAOYSA-N

Application

Tegafur has been used as an internal standard for the analysis of 5′DFCR (5′deoxyfluorocytidine) and 5′DFUR (5′deoxyfluorouridine) using HPLC techniques[1]. Tegafur has also been used as an internal standard for the chromatographic assay of azidothymidine (AZT)[2].

Biochem/physiol Actions

Tegafur is a pro-drug of 5-fluorouracil, an antimetabolite used as an antineoplastic agent. It has been used as adjuvant chemotherapy for curatively resected colorectal cancer therapy.

Preparation Note

Tegafur is soluble in DMSO at a concentration that is greater than 50 mg/ml.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
F5307PZ0215PZ0327
Tegafur powder

Sigma-Aldrich

T7205

Tegafur

5−Fluoro−2′−deoxycytidine ≥98% (HPLC), powder

Sigma-Aldrich

F5307

5−Fluoro−2′−deoxycytidine

PF-04701475 ≥98% (HPLC)

Sigma-Aldrich

PZ0215

PF-04701475

PF06650833 ≥98% (HPLC)

Sigma-Aldrich

PZ0327

PF06650833

form

powder

form

powder

form

powder

form

powder

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

storage temp.

room temp

storage temp.

room temp

storage temp.

room temp

storage temp.

room temp

solubility

DMSO: >50 mg/mL

solubility

DMSO: >20 mg/mL

solubility

DMSO: 5 mg/mL, clear

solubility

DMSO: 20 mg/mL, clear

color

white to off-white

color

white to off-white

color

white to beige

color

white to beige

pictograms

Skull and crossbones
GHS06

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000494941
0000494938
0000494938
0000494941
0000232769

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Li-Feng Liu et al.
Chinese medical journal, 125(11), 1931-1935 (2012-08-14)
The pharmacokinetics of zidovudine (AZT) are possibly influenced by weight, age, sex, liver and renal functions, severity of disease, and ethnicity. Currently, little information is available on the steady-state pharmacokinetics of AZT in Chinese HIV-infected patients. The current study aimed
Thierry Besnard et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 870(1), 117-120 (2008-06-20)
The 5FU prodrug capecitabine undergoes a 3-step enzymatic conversion, including the conversion of 5'DFRC into 5'DFUR by cytidine deaminase (CDA). The presence of CDA activity in blood led us to analyze the possible ex vivo conversion of 5'DFCR into 5'DFUR
Terence C Tang et al.
Neoplasia (New York, N.Y.), 12(3), 264-274 (2010-03-18)
Hepatocellular carcinoma (HCC) is an intrinsically chemotherapy refractory malignancy. Development of effective therapeutic regimens would be facilitated by improved preclinical HCC models. Currently, most models consist of subcutaneous human tumor transplants in immunodeficient mice; however, these do not reproduce the
View All Related Papers

Global Trade Item Number

SKUGTIN
T7205-25MG04061833026182
T7205-5MG04061833026199

Questions

Reviews

No rating value

Active Filters